Wed. 8 May 2024, 7:14am ET
Benzinga
News, Guidance
For 2024, R1 now expects to generate:
- Revenue of $2.60 billion to $2.64 billion
- GAAP operating income of $85 million to $105 million
- Adjusted EBITDA of $625 million to $650 million
The updated guidance reflects the impacts of the Change Healthcare cyberattack on first quarter and expected full year 2024 revenue related to collections timing, claims inflows, and the ability to meet key performance metrics, as well as increased expenses to support our customers.